Bodhi Tree Biotechnology Inc Financials

Bodhi Tree Biotechnology Inc (BDTB) reported $17K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

No, Bodhi Tree Biotechnology Inc (BDTB) reported a net income of -$150K in fiscal year 2025, with a net profit margin of -880.4%.

Bodhi Tree Biotechnology Inc (BDTB) reported diluted earnings per share of $-0.01 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Bodhi Tree Biotechnology Inc (BDTB) had an operating margin of -868.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Bodhi Tree Biotechnology Inc (BDTB) had a net profit margin of -880.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Bodhi Tree Biotechnology Inc (BDTB) has a return on equity of -125.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Bodhi Tree Biotechnology Inc (BDTB) generated -$150K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Bodhi Tree Biotechnology Inc (BDTB) had $119K in total assets as of fiscal year 2025, including both current and long-term assets.

Bodhi Tree Biotechnology Inc (BDTB) had 25M shares outstanding as of fiscal year 2025.

Bodhi Tree Biotechnology Inc (BDTB) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Bodhi Tree Biotechnology Inc (BDTB) had a return on assets of -125.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Bodhi Tree Biotechnology Inc (BDTB) had $109K in cash against an annual operating cash burn of $150K. This gives an estimated cash runway of approximately 9 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Bodhi Tree Biotechnology Inc (BDTB) has an earnings quality ratio of 1.00x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Bodhi Tree Biotechnology Inc (BDTB) has an interest coverage ratio of -73809.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.